http://www.PR.com/ Latest news releases from PR.com for GTCbio. Tue, 14 Feb 2012 16:54:48 -0500 © 2012 PR Worldwide, Inc. 60 en-us http://www.PR.com/images/logo_white.jpg http://www.PR.com/ 68 69 PR.com provides Free Press Release Distribution, & is a unique Directory of Businesses, Products, Services, & Jobs - in all industries. Find Full Company Profiles. http://www.pr.com/press-release/280100 Fri, 26 Nov 2010 15:15:44 -0500 Thomas Li, Senior Director of Technology Management and US Chief Technology Officer at Hoffmann - La Roche to give a presentation on “Oncology Biomarker Discovery Technologies of Today and Tomorrow” at GTCbio’s 3rd Oncology Biomarkers Conference on January 27-28, 2011 in San Diego, CA. Dr. Li will review the past and present biomarker discovery technologies. Technology examples will be drawn from [PR.com] http://www.pr.com/press-release/280100 GTCbio http://www.pr.com/press-release/279332 Thu, 25 Nov 2010 03:00:00 -0500 Jeremy Barton, VP of Oncology at Biogen Idec will be the keynote presenter on “Targeted Drug Delivery: How Far from the Bulls Eye?” at GTCbio’s Cancer Drugs Research & Development Conference on January 27-28, 2011 in San Diego, CA. Dr. Barton will address why the narrow therapeutic window of most cytotoxic drugs has limited their benefit in the clinic and normal tissue toxicity constrains the dose [PR.com] http://www.pr.com/press-release/279332 GTCbio http://www.pr.com/press-release/219849 Wed, 17 Mar 2010 03:00:00 -0400 Andrew Crew, Director of Cancer Chemistry at OSI Pharmaceuticals will give a presentation on “Imidazo[1,5-a]pyrazines: Selective and Orally Efficacious mTORC1/2 Inhibitors” at the 5th Annual Protein Kinases in Drug Discovery conference to be held this year in Boston, MA on May 27-28, 2010 by GTCbio. [PR.com] http://www.pr.com/press-release/219849 GTCbio http://www.pr.com/press-release/219332 Sun, 14 Mar 2010 03:00:00 -0400 Katy Spink, Vice President of Operations for Geron, will give the Featured presentation at GTCbio’s 6th Stem Cell Research & Therapeutics Conference, May 27-28, 2010 in Boston, MA. [PR.com] http://www.pr.com/press-release/219332 GTCbio http://www.pr.com/press-release/219084 Sat, 13 Mar 2010 03:00:00 -0500 Barbara Wirostko, Senior Medical Director, Team Lead Ophthalmology, Pfizer will give a presentation at GTCbio’s 2nd Annual Ocular Disease Drug & Discovery Conference, May 27 – 28, 2010 in Boston, MA. [PR.com] http://www.pr.com/press-release/219084 GTCbio http://www.pr.com/press-release/173241 Fri, 21 Aug 2009 03:00:00 -0400 GTCbio’s 5th Annual Modern Drug Discovery & Development Conference (to be held October 14-16, 2009 in San Diego, CA) has an important focus on Stem Cell Discovery & Development. The Stem Cell track is to deliver information regarding cutting-edge developments in all areas of stem cell research. [PR.com] http://www.pr.com/press-release/173241 GTCbio http://www.pr.com/press-release/172642 Wed, 19 Aug 2009 03:00:00 -0400 GTCbio’s 5th Annual Modern Drug Discovery & Development Conference (held on October 14-16, 2009 in San Diego, CA) has placed a focus upon Translational Medicine with its individual Track. The Summit gives attendees from scientists to patients the opportunity to meet and discuss. [PR.com] http://www.pr.com/press-release/172642 GTCbio http://www.pr.com/press-release/168883 Fri, 31 Jul 2009 03:00:00 -0400 Amy Scott-Billman, Vice President of Global Regulatory Strategy for Immunotherapeutics at GlaxoSmithKline Biologicals, is to give a keynote presentation concerning regulatory considerations & challenges for immunotherapeutic/diagnostic co-development at GTCbio’s 5th Modern Drug Discovery & Development Summit, on October 14th-16th, 2009, in San Diego, CA. [PR.com] http://www.pr.com/press-release/168883 GTCbio http://www.pr.com/press-release/164017 Thu, 09 Jul 2009 03:00:00 -0400 The conference is in session from October 1-2, 2009 in Lisbon, Portugal with topics ranging from how to decrease the cost of drug discovery to translational research. [PR.com] http://www.pr.com/press-release/164017 GTCbio http://www.pr.com/press-release/138379 Sat, 14 Mar 2009 03:00:00 -0400 Alison Goss Eng, from the United States Department of Energy will be the featured speaker at GTCbio’s Inaugural Biofuels: Science and Innovation for Sustainable Development Conference on June 28-30, 2009 in San Francisco, California. Alison Goss Eng will deliver her featured address entitled “U.S. Department of Energy Biomass Program: Integrated Research Targeting Sustainability Challenges to Promote Industry [PR.com] http://www.pr.com/press-release/138379 GTCbio http://www.pr.com/press-release/128075 Sat, 24 Jan 2009 03:00:00 -0500 Dr. Susan Richards, Group VP of Clinical Laboratory Sciences at Genzyme is scheduled to give the keynote presentation at GTCbio’s 3rd annual Immunodiagnostics & Immunomonitoring Conference. [PR.com] http://www.pr.com/press-release/128075 GTCbio http://www.pr.com/press-release/125070 Thu, 08 Jan 2009 03:00:00 -0500 Thomas A. Waldmann, M.D., Chief of the Metabolism Branch at the NCI, NIH will give the keynote presentation at GTCbio’s at 3rd Annual Immunodiagnostics & Immunomonitoring Conference on April 23-24, 2009 in Chicago, IL. [PR.com] http://www.pr.com/press-release/125070 GTCbio http://www.pr.com/press-release/124393 Fri, 02 Jan 2009 03:00:00 -0500 Charles Peterfy, Chief Scientific Officer at Synarc will give the featured presentation at GTCbio’s 4th annual Imaging in Preclinical & Clinical Drug Development Conference on March 16-17, 2009 in San Francisco, CA. [PR.com] http://www.pr.com/press-release/124393 GTCbio http://www.pr.com/press-release/124116 Wed, 31 Dec 2008 03:00:00 -0500 Gregory A. Bonfiglio, Managing Partner at Proteus Venture Partners will give the featured presentation at GTCbio’s 5th Stem Cell Research & Therapeutics Conference on March 9-10, 2009 in Boston, MA. [PR.com] http://www.pr.com/press-release/124116 GTCbio http://www.pr.com/press-release/121503 Fri, 12 Dec 2008 03:00:00 -0500 Dr. De Yang, Senior Scientist of the Cellular Immunology Group at the National Cancer Institute of the National Institutes of Health will present at the 7th Cytokines & Inflammation Conference on January 29-30, 2009 in San Diego, CA. [PR.com] http://www.pr.com/press-release/121503 GTCbio http://www.pr.com/press-release/117362 Wed, 19 Nov 2008 03:00:00 -0500 GTCbio just announced its 2nd Annual Oncology Biomarkers Conference taking place on January 19-20, 2009 in Miami, Florida. The conference will take attendees through “The Life Cycle of a Cancer Biomarker”; examining the path from the identification of a candidate biomarker, development through validation, onto the clinic to be able to identify unmet needs and spark new discoveries back in the laboratory. This [PR.com] http://www.pr.com/press-release/117362 GTCbio http://www.pr.com/press-release/117363 Wed, 19 Nov 2008 03:00:00 -0500 Dr. Samir Hanash, Program Head at the Fred Hutchinson Cancer Research Center in Seattle, WA will give the keynote address on the discovery and development of biomarkers at the 2nd annual Oncology Biomarkers Conference on January 19-20 in Miami, Florida. Dr. Hanash will present on findings from studies of epithelial cancers, particularly lung and pancreatic cancer, which have transitioned from discovery to validation in [PR.com] http://www.pr.com/press-release/117363 GTCbio http://www.pr.com/press-release/115163 Fri, 07 Nov 2008 03:00:00 -0500 GTCbio announced its Inaugural CNS Partnering & Deal-Making Summit being held on December 1-2, 2008 in Boston, MA. This event is one of the leading CNS disease partnering forums bringing together members of government, industry and academia to discuss the latest advancements in the field. Leaders in business development and CNS diseases will present on new advancements in CNS disease research and development [PR.com] http://www.pr.com/press-release/115163 GTCbio http://www.pr.com/press-release/101715 Sat, 23 Aug 2008 03:00:00 -0400 Dr. Johan Luthman, Global Head of Exploratory Medicine Neurology at MerckSerono International in Geneva, Switzerland will present at the Plenary Keynote session at GTCbio’s 4th Modern Drug Discovery and Development Summit on October 15-17, 2008 at the Hilton La Jolla Torrey Pines in La Jolla, CA. Dr. Luthman’s presentation entitled “Small Pharma, Big Pharma and Small Drugs and Big Drugs; Or Middle Way [PR.com] http://www.pr.com/press-release/101715 GTCbio http://www.pr.com/press-release/101291 Thu, 21 Aug 2008 13:57:00 -0400 Dr. Stanley Deresinski, Clinical Professor of Medicine-Med/Infectious Diseases at Stanford University in Palo Alto, CA will speak on “The Seemingly Never-ending Promise of Bacteriophage Therapy: Exploiting Smaller Fleas” at GTCbio’s Bugs & Drug Conf. on Sept. 22-23, 2008 at the DoubleTree Club Hotel in San Diego, CA. Dr. Deresinski will speak on the renewed interest in Phage Therapy. Administration [PR.com] http://www.pr.com/press-release/101291 GTCbio http://www.pr.com/press-release/101289 Thu, 21 Aug 2008 13:54:00 -0400 Sharath Hegde, Vice President of Pharmacology at Theravance, Inc. in South San Francisco, CA will speak on “Telavancin: A Novel Lipoglycopeptide Gram-Positive Antibiotic” at GTCbio’s Bugs & Drug Conference on September 22-23, 2008 at the DoubleTree Club Hotel in San Diego, CA. Telavancin (TLV) is an investigational lipoglycopeptide antibiotic that has broad-spectrum activity against Gram-positive [PR.com] http://www.pr.com/press-release/101289 GTCbio http://www.pr.com/press-release/101287 Thu, 21 Aug 2008 13:50:00 -0400 Dr. Rita Helfand, Associate Director of Epidemiologic Science at the National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention will speak on “Controlling Infectious Diseases: Progress and Challenges in Addressing Known and Unknown Threats” at GTCbio’s Bugs & Drug Conference on September 22-23, 2008 at the DoubleTree Club Hotel in San [PR.com] http://www.pr.com/press-release/101287 GTCbio http://www.pr.com/press-release/101286 Thu, 21 Aug 2008 13:42:00 -0400 Dr. Barry Eisenstein, Senior Vice President of Scientific Affairs at Cubist Pharmaceuticals in Lexington, MA and Clinical Professor of Medicine, Harvard Medical School in Cambridge, MA gives the keynote address on getting congress to understand the need for antibiotic development. In contrast to the discovery and development of other therapeutic areas, antimicrobials, and specifically anti-bacterial agents, have unique [PR.com] http://www.pr.com/press-release/101286 GTCbio http://www.pr.com/press-release/99545 Sat, 09 Aug 2008 18:14:00 -0400 Dr. Ashraf Hanna, Vice President of Alliance Management and Portfolio Planning at Genentech in San Francisco, CA will present at the Plenary Keynote session at GTCbio’s 4th Modern Drug Discovery and Development Summit on October 15-17, 2008 in La Jolla, CA. Dr. Hanna will present on The Cost and Benefit of Portfolio Innovation. In his presentation, Dr. Hanna will review historical drug development costs and its [PR.com] http://www.pr.com/press-release/99545 GTCbio http://www.pr.com/press-release/99544 Sat, 09 Aug 2008 18:13:00 -0400 GTCbio just announced the commencement of its inaugural conference on Global Clinical Trial Operations taking place on September 25-26, 2008 in San Diego, CA. Outsourcing to CROs has proven to be much more cost effective and less time consuming when conducting clinical trials. The steps to ensuring a successful trial are long and crucial to the approval of a drug. Companies must consider many aspects of a clinical trial [PR.com] http://www.pr.com/press-release/99544 GTCbio http://www.pr.com/press-release/99543 Sat, 09 Aug 2008 18:11:00 -0400 GTCbio just announced the 3rd edition of its Biomarker Series – the Biomarker Discovery Europe Conference - taking place on October 2-3, 2008 in Dublin, Ireland. Over the last several years, biomarkers have been an increasingly important and a heavily researched topic at all of the leading pharmaceutical and biotech companies worldwide. There have been many new advancements in the technologies used to facilitate [PR.com] http://www.pr.com/press-release/99543 GTCbio http://www.pr.com/press-release/99539 Sat, 09 Aug 2008 17:00:00 -0400 GTCbio just announced its inaugural Bugs & Drugs conference – one of the leading forums to address unmet medical needs for problematic microbials - taking place on September 22-23, 2008 in San Diego, CA. Infections are becoming increasingly problematic due to the recent resistances to current antibiotics. Patients suffering from resistant bugs (hospital-acquired or community-acquired) now need new yet [PR.com] http://www.pr.com/press-release/99539 GTCbio http://www.pr.com/press-release/99541 Sat, 09 Aug 2008 17:00:00 -0400 GTCbio just announced the scheduling of its 4th annual Neurodegenerative Diseases Drug Discovery Conference on October 9-10, 2008 in Philadelphia, PA. Neurodegenerative diseases continue to play an enormous role in the growing public health problem, disrupting the quality of life of millions of people and costing society billions of dollars annually. Nonetheless, in the last few years, there has been great progress in [PR.com] http://www.pr.com/press-release/99541 GTCbio http://www.pr.com/press-release/95748 Fri, 18 Jul 2008 03:00:00 -0400 Dr. Robert J. Davie, Vice President & General Manager of Clinical Development Services - Europe at Covance will give a presentation entitled “The Service Provider Perspective: How are CROs Preparing for the Future of Clinical Outsourcing?” at GTCbio’s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA. [PR.com] http://www.pr.com/press-release/95748 GTCbio http://www.pr.com/press-release/91249 Fri, 20 Jun 2008 03:00:00 -0400 Brahm Goldstein Novo Nordisk speaking regarding a rational approach towards pediatric drug development in the pharmaceutical industry at GTCbio’s Global Clinical Trial Operations Conference on 9/25-26. [PR.com] http://www.pr.com/press-release/91249 GTCbio http://www.pr.com/press-release/91251 Fri, 20 Jun 2008 03:00:00 -0400 Charlene Dark, Dir. of Life Sciences at Clarkston Consulting will be present on expediting accuracy through electronic data capture at GTCbio’s Global Clinical Trial Operations Conference on Sept. 25-26 in San Diego. [PR.com] http://www.pr.com/press-release/91251 GTCbio http://www.pr.com/press-release/91252 Fri, 20 Jun 2008 03:00:00 -0400 Cosimo Spera from Decision View Co. will give a presentation entitled “Marrying Complex Mathematical Models with Highly Usable Software Solutions to Improve Trial Enrollment Performance” at GTCbio’s Global Clinical Trial Operations Conference. [PR.com] http://www.pr.com/press-release/91252 GTCbio http://www.pr.com/press-release/90751 Wed, 18 Jun 2008 03:00:00 -0400 Amrit Ray, Vice President of Bristol-Myers Squibb will give the keynote presentation at GTCbio’s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA. Dr. Ray will give a presentation entitled “The Next Generation of Pharmacovigilance - Clinical Trials and Drug Development in the New Era of Drug Safety. [PR.com] http://www.pr.com/press-release/90751 GTCbio http://www.pr.com/press-release/89905 Fri, 13 Jun 2008 03:00:00 -0400 Paul Watt, Vice President of Drug Discovery at Phylogica to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference on September 8-9, 2008 in San Diego, CA. [PR.com] http://www.pr.com/press-release/89905 GTCbio http://www.pr.com/press-release/89907 Fri, 13 Jun 2008 03:00:00 -0400 Lino Gonzalez from Genentech to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference on September 8-9, 2008 in San Diego, CA. [PR.com] http://www.pr.com/press-release/89907 GTCbio http://www.pr.com/press-release/89909 Fri, 13 Jun 2008 03:00:00 -0400 Kanji Takada, Group Leader of Experimental Therapeutics at Celgene to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference on September 8-9, 2008 in San Diego, CA. [PR.com] http://www.pr.com/press-release/89909 GTCbio http://www.pr.com/press-release/89911 Fri, 13 Jun 2008 03:00:00 -0400 David Szymkowski, Senior Director of Biotherapeutics at Xencor will Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference on September 8-9, 2008 in San Diego, CA [PR.com] http://www.pr.com/press-release/89911 GTCbio http://www.pr.com/press-release/89699 Thu, 12 Jun 2008 03:00:00 -0400 Dr. Keith James, Senior Vice President and Site Head of Pfizer La Jolla will present at the Plenary Keynote session at GTCbio’s 4th Modern Drug Discovery and Development Summit on October 15-17, 2008 at the Hilton La Jolla Torrey Pines in La Jolla, CA. Dr. James’ will speak on the challenges & opportunities of driving global R&D performance. His presentation will explore approaches taken at Pfizer to [PR.com] http://www.pr.com/press-release/89699 GTCbio http://www.pr.com/press-release/81489 Wed, 30 Apr 2008 17:53:00 -0400 Dr. Y. Gloria Meng, Senior Scientist of Technology at Genentech will give a presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA. Dr. Meng will speak on electrochemiluminescence to detect surface proteins on live cells. [PR.com] http://www.pr.com/press-release/81489 GTCbio http://www.pr.com/press-release/81213 Fri, 18 Apr 2008 03:00:00 -0400 Dr. Matthew Olson, Principle Research Scientist at Johnson & Johnson will give a presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Olsen will present on “Coupling Label-free and Flouormetric Functional Assays with Biophysical Binding Assays: A Comparison of Positives from an HTS Campaign.” HTS campaigns continue to push [PR.com] http://www.pr.com/press-release/81213 GTCbio